Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia: results of a prospective study in Japan-Reference-Cited by-同舟云学术

Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia: results of a prospective study in Japan

Published:2010-06-25 Issue:1 Volume:92 Page:111-117
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Nagai Tadashi,Takeuchi Jin,Dobashi Nobuaki,Kanakura Yuzuru,Taniguchi Shuichi,Ezaki Koji,Nakaseko Chiaki,Hiraoka Akira,Okada Masaya,Miyazaki Yasushi,Motoji Toshiko,Higashihara Masaaki,Tsukamoto Norifumi,Kiyoi Hitoshi,Nakao Shinji,Shinagawa Katsuji,Ohno Ryuzo,Naoe Tomoki,Ohnishi Kazunori,Usui Noriko

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-010-0621-x.pdf

Reference16 articles.

1. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med. 1996;2:561–6.

2. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Eng J Med. 2001;344:1031–7.

3. O’Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Eng J Med. 2003;348:994–1004.

4. Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C, et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Eng J Med. 2002;346:645–52.

5. de Lavallade H, Apperley JF, Khorashad JS, Milojkovic D, Reid AG, Bua M, et al. Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis. J Clin Oncol. 2008;26:3358–63.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematological Adverse Events with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review with Meta-Analysis;Cancers;2023-08-31

2. A case of severe digital vasculopathy during imatinib therapy in a hemodialysis patient with chronic myeloid leukemia;Nihon Toseki Igakkai Zasshi;2016

3. A sharp fluctuation in peripheral blood cells shortly after dasatinib administration;International Journal of Hematology;2012-07-15

4. Long-term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study;Cancer Science;2012-04-16

5. CML treatment in Asia–Pacific region;Hematology;2012-04-01